and retatrutide targets the GLP-1, GIP, and glucagon hormones
Significance cut-offs are listed in figure legends for each analysis
Exercise Capacity Improvement after Cardiac Rehabilitation Following Myocardial Infarction and its Association with Long-Term Cardiovascular Events
The class also carries a boxed warning regarding the potential risk of thyroid C-cell tumours, applicable across all semaglutide formulations and extended to Foundayo in its prescribing information
Also, it is well-tolerated, efficacious, and safe to use
It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia ( In the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg were compared to the GLP-1RA semaglutide (1 mg once weekly) in patients not well controlled in therapy only with metformin (71)